Analytical testing, QC

95 Results

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Frontage Laboratories | 01-Dec-2019 | Technical / White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Frontage Laboratories | 21-Aug-2019 | Technical / White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

BBK Worldwide | 24-Jul-2019 | Technical / White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

William Reed | 27-Jul-2017 | Application Note

In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...

The Power to Make, A Virtual Tour

Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

Product Innovations

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...

Analytical testing, QC

95 Results

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

How to Avoid Surprises in Small-Molecule Drug Development Programs

Validating The Simoa Technology

Assessing Pre-Existing Antibodies in Biotheraputic Development

The Truth about Physician Referrals and Clinical Trials

Stability Testing As a Quality Control Measure

Survey Report: State of the global pharmaceutical contract services industry 2018

Advancing therapeutics for myeloma

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

The Power to Make, A Virtual Tour

Suppliers

Baxter BioPharma Solutions

Frontage Laboratories

Marken

BBK Worldwide

Ajinomoto Bio-Pharma Services

R-Pharm Germany GmbH

Follow us

Related News

Product Innovations

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

Promotional Features

Free newsletter sign up

Outsourcing-Pharma

Resources